Publications by authors named "Johan Abrahamsson"

Claim this Profile
M
Molecular Subtypes Are Associated With Clinical Benefit in Cisplatin-Treated Metastatic Urothelial Cancer Patients.
Karin Holmsten, Gottfrid Sjödahl, Johan Abrahamsson, Carina Bernardo, Pontus Eriksson

JCO Precis Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Violation of onco-surgical principles is associated with survival outcomes in upper tract urothelial carcinomas after radical nephroureterectomy.
Ioannis Patras, Johan Abrahamsson, Axel Gerdtsson, Martin Nyberg, Ymir Saemundsson

Scand J Urol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer.
Gottfrid Sjödahl, Pontus Eriksson, Karin Holmsten, Johan Abrahamsson, Mattias Höglund

Int J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma: Results from a Prospective Lymph Node Mapping Study.
Johannes Bobjer, Axel Gerdtsson, Johan Abrahamsson, Gediminas Baseckas, Mats Bergkvist

Eur Urol Open Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET/CT for lymph node staging prior to radical cystectomy.
Vilhelm Pihl, Maria Markus, Johan Abrahamsson, Mats Bläckberg, Oskar Hagberg

Eur J Hybrid Imaging· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urosymphyseal fistula after pelvic radiotherapy in a tertial referral centre - a rare entity with significant comorbidity requiring multidisciplinary management.
Johan Brändstedt, Johan Abrahamsson, Gediminas Baseckas, Johannes Bobjer, Axel Gerdtsson

Scand J Urol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice - from biobank to RNA-sequencing in real time.
Fredrik Liedberg, Johan Abrahamsson, Carina Bernardo, Mats Bläckberg, Anders Edsjö

Scand J Urol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes.
Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, Carina Bernardo, Gunilla Chebil

Eur Urol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?
Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, Carina Bernardo, Pontus Eriksson

Eur Urol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer-A Narrative Review.
Gottfrid Sjödahl, Johan Abrahamsson, Carina Bernardo, Pontus Eriksson, Mattias Höglund

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete metabolic response with [ F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer.
Johan Abrahamsson, Petter Kollberg, Helen Almquist, Mats Bläckberg, Johan Brändstedt

BJU Int· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy.
Fredrik Liedberg, Johan Abrahamsson, Johannes Bobjer

Eur Urol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival.
Johan Abrahamsson, Kristina Aaltonen, Helgi Engilbertsson, Fredrik Liedberg, Oliver Patschan

Urol Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis